Sufentanil Sublingual Tablet System: from rationale of use to clinical practice.

MLA

Vergari, A., et al. “Sufentanil Sublingual Tablet System: From Rationale of Use to Clinical Practice.” European Review for Medical & Pharmacological Sciences, vol. 24, no. 22, Nov. 2020, pp. 11891–99. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=147795546&authtype=sso&custid=ns315887.

APA

Vergari, A., Cortegiani, A., Rispoli, M., Coluzzi, F., Deni, F., Leykin, Y., Lorin, F. L., Martorano, P. P., Paolicchi, A., Polati, E., Scardino, M., Corcione, A., Giarratano, A., & Rossi, M. (2020). Sufentanil Sublingual Tablet System: from rationale of use to clinical practice. European Review for Medical & Pharmacological Sciences, 24(22), 11891–11899.

Chicago

Vergari, A., A. Cortegiani, M. Rispoli, F. Coluzzi, F. Deni, Y. Leykin, F. Luca Lorin, et al. 2020. “Sufentanil Sublingual Tablet System: From Rationale of Use to Clinical Practice.” European Review for Medical & Pharmacological Sciences 24 (22): 11891–99. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=147795546&authtype=sso&custid=ns315887.